Andrew More is a Director at BlueStone Venture Partners. At BlueStone, Andrew is primarily responsible for leading diligence activities on prospective investments in addition to managing various portfolio and internal fund activities.
Andrew currently is a Board Observer at Elucid and Pyx Health and previously was a Board Observer at Paradigm Diagnostics. He is also a member of the Board of Directors for Tucson Young Professionals and serves on the Eller Alumni Advisory Council for the University of Arizona's Eller College of Management.
Andrew was the recipient of The M&A Advisor's Emerging Leader Award and has been recognized by the Global M&A Network as one of America's Rising Stars in the Dealmaker category.
Before joining BlueStone, Andrew was an Investment Fellow at the UVA LVG Seed Fund in Charlottesville, Virginia where he performed diligence on early-stage life sciences startups seeking Seed and Series A funding.
Previously, he was a Senior Associate at Tregaron Capital, a Palo Alto-based private equity fund, where he executed lower middle-market buyouts across a variety of industries. Andrew also worked for Ernst & Young’s Transaction Support team where he provided financial due diligence and advisory services for middle-market private equity clients.
Andrew received a BSBA in Accounting and Finance from the University of Arizona, a MAcc from the University of Southern California, and an MBA with a triple concentration from the University of Virginia Darden School of Business. He is a licensed CPA in the state of California.
Copyright 2022 © BlueStone Venture Partners